During the last session, Xilio Therapeutics Inc (NASDAQ:XLO)’s traded shares were 0.31 million, with the beta value of the company hitting -0.25. At the end
In the last trading session, 1.53 million Xilio Therapeutics Inc (NASDAQ:XLO) shares changed hands as the company’s beta touched -0.26. With the company’s per share
Xilio Therapeutics Inc (NASDAQ:XLO) has a beta value of -0.31 and has seen 1.24 million shares traded in the last trading session. The company, currently
Xilio Therapeutics Inc (NASDAQ:XLO) has a beta value of -0.31 and has seen 0.78 million shares traded in the recent trading session. The company, currently
During the last session, Xilio Therapeutics Inc (NASDAQ:XLO)’s traded shares were 0.58 million, with the beta value of the company hitting -0.37. At the end
Xilio Therapeutics Inc (NASDAQ:XLO)’s traded shares stood at 0.41 million during the last session, with the company’s beta value hitting -0.39. At the close of
In the last trading session, 2.39 million Xilio Therapeutics Inc (NASDAQ:XLO) shares changed hands as the company’s beta touched -0.31. With the company’s per share
In the last trading session, 3.36 million Xilio Therapeutics Inc (NASDAQ:XLO) shares changed hands as the company’s beta touched -0.24. With the company’s per share
In recent trading session, Xilio Therapeutics Inc (NASDAQ:XLO) saw 1.42 million shares changing hands at last check today with its beta currently measuring -0.24. Company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
